Manzo Pharmaceut Stock Buy Hold or Sell Recommendation
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Manzo Pharmaceut is 'Strong Sell'. The recommendation algorithm takes into account all of Manzo Pharmaceut's available fundamental, technical, and predictive indicators you will find on this site.
Check out Manzo Pharmaceut Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Manzo Stock, please use our How to Invest in Manzo Pharmaceut guide. In addition, we conduct extensive research on individual companies such as Manzo and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Manzo Pharmaceut. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Manzo |
Execute Manzo Pharmaceut Buy or Sell Advice
The Manzo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Manzo Pharmaceut. Macroaxis does not own or have any residual interests in Manzo Pharmaceut or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Manzo Pharmaceut's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Manzo Pharmaceut Trading Alerts and Improvement Suggestions
| Manzo Pharmaceut generated a negative expected return over the last 90 days | |
| Manzo Pharmaceut has some characteristics of a very speculative penny stock | |
| Manzo Pharmaceut currently holds 11.09 K in liabilities. Manzo Pharmaceut has a current ratio of 0.2, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Manzo Pharmaceut's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 2.01 K. Net Loss for the year was (36.24 K) with profit before overhead, payroll, taxes, and interest of 20.97 K. | |
| Manzo Pharmaceut has a frail financial position based on the latest SEC disclosures |
Manzo Pharmaceut Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Manzo Pharmaceut or Capital Markets sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Manzo Pharmaceut's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Manzo stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Manzo Pharmaceut Volatility Alert
At this time Manzo Pharmaceut exhibits very low volatility. You can indeed make money on Manzo instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Manzo Pharmaceut Fundamentals Vs Peers
Comparing Manzo Pharmaceut's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Manzo Pharmaceut's direct or indirect competition across all of the common fundamentals between Manzo Pharmaceut and the related equities. This way, we can detect undervalued stocks with similar characteristics as Manzo Pharmaceut or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Manzo Pharmaceut's fundamental indicators could also be used in its relative valuation, which is a method of valuing Manzo Pharmaceut by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Manzo Pharmaceut to competition |
| Fundamentals | Manzo Pharmaceut | Peer Average |
| Current Valuation | 11.6 K | 16.62 B |
| Shares Outstanding | 1.16 B | 571.82 M |
| Revenue | 2.01 K | 9.43 B |
| Gross Profit | 20.97 K | 27.38 B |
| EBITDA | (4.24 M) | 3.9 B |
| Net Income | (36.24 K) | 570.98 M |
| Cash And Equivalents | 21 | 2.7 B |
| Total Debt | 11.09 K | 5.32 B |
| Current Ratio | 0.20 X | 2.16 X |
| Cash Flow From Operations | 275.76 K | 971.22 M |
| Number Of Employees | 12 | 18.84 K |
| Beta | -44.7 | -0.15 |
| Market Capitalization | 11.6 K | 19.03 B |
| Total Asset | 192.41 K | 29.47 B |
| Retained Earnings | (12.4 M) | 9.33 B |
| Working Capital | 23 K | 1.48 B |
| Current Asset | 15 K | 9.34 B |
| Current Liabilities | (8 K) | 7.9 B |
| Net Asset | 192.41 K |
About Manzo Pharmaceut Buy or Sell Advice
When is the right time to buy or sell Manzo Pharmaceut? Buying financial instruments such as Manzo Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Manzo Pharmaceut in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Furniture Thematic Idea Now
Furniture
Companies producing and selling home and office furniture. The Furniture theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Furniture Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Manzo Pharmaceut Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Manzo Stock, please use our How to Invest in Manzo Pharmaceut guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Manzo Pharmaceut. If investors know Manzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Manzo Pharmaceut listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Manzo Pharmaceut is measured differently than its book value, which is the value of Manzo that is recorded on the company's balance sheet. Investors also form their own opinion of Manzo Pharmaceut's value that differs from its market value or its book value, called intrinsic value, which is Manzo Pharmaceut's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Manzo Pharmaceut's market value can be influenced by many factors that don't directly affect Manzo Pharmaceut's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Manzo Pharmaceut's value and its price as these two are different measures arrived at by different means. Investors typically determine if Manzo Pharmaceut is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Manzo Pharmaceut's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.